Contact
searchSearch
HMP Global

Pediatric Dermatology

Featured

FDA Alerts
FDA Approves Vyjuvek for Treatment of Wounds in Patients with Dystrophic Epidermolysis Bullosa
08/10/2023
Jessica Garlewicz
The US Food and Drug Administration recently announced approval of VYJUVEK (beremagene geperpavec [B-VEC]) for the treatment of wounds in patients ages 6 months and older with dystrophic epidermolysis bullosa.
The US Food and Drug Administration recently announced approval of VYJUVEK (beremagene geperpavec [B-VEC]) for the treatment of wounds in patients ages 6 months and older with dystrophic epidermolysis bullosa.
The US Food and Drug...
08/10/2023
The Dermatologist
News
Patients With Pediatric Granuloma Annulare Often Present With Asthma and Atopy
01/31/2023
Lisa Kuhns, PhD, MD
Researchers aimed to perform a clinical and histopathologic evaluation of 41 pediatric GA cases in a retrospective study.
Researchers aimed to perform a clinical and histopathologic evaluation of 41 pediatric GA cases in a retrospective study.
Researchers aimed to perform a...
01/31/2023
The Dermatologist
CH
Videos
How to Teach Families About Safe Hair Care for Skin of Color
01/17/2022
Candrice Heath, MD, FAAP, FAAD
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses...
01/17/2022
The Dermatologist
CH
Videos
Integrating Skin of Color Hair Care for Young Patients
01/09/2022
Candrice Heath, MD, FAAP, FAAD
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath,...
01/09/2022
The Dermatologist
News
Tobacco Exposure Linked to Childhood Psoriasis
12/23/2021
Lauren Mateja
A study in Pediatric Dermatology found that environmental tobacco smoke exposure at home was associated with childhood psoriasis in a Turkish population study.
A study in Pediatric Dermatology found that environmental tobacco smoke exposure at home was associated with childhood psoriasis in a Turkish population study.
A study in Pediatric Dermatology...
12/23/2021
The Dermatologist
News
Paraben Exposure Increases Atopic Dermatitis Prevalence in Young Children
12/18/2021
Lisa Kuhns, PhD, MD
High exposure to parabens in children aged 0 to 3 years increased the prevalence of atopic dermatitis (AD), according to a recent study from Japan.
High exposure to parabens in children aged 0 to 3 years increased the prevalence of atopic dermatitis (AD), according to a recent study from Japan.
High exposure to parabens in...
12/18/2021
The Dermatologist
News
Atopic Dermatitis Associated With Shorter Stature and Higher BMI in Children
12/13/2021
Lisa Kuhns, PhD, MD
Atopic dermatitis in children is associated with shorter stature, higher BMI, and lower weight in early childhood, but these associations resolve with age.
Atopic dermatitis in children is associated with shorter stature, higher BMI, and lower weight in early childhood, but these associations resolve with age.
Atopic dermatitis in children is...
12/13/2021
The Dermatologist
News
Pediatric Urticaria Resolution Associated With Elevated CD63 Levels and Thyroid Comorbidity
04/13/2021
Elevated CD63 levels and thyroid disease are associated with chronic inducible urticaria (CIndU) resolution in pediatric patients.
Elevated CD63 levels and thyroid disease are associated with chronic inducible urticaria (CIndU) resolution in pediatric patients.
Elevated CD63 levels and thyroid...
04/13/2021
The Dermatologist
News
Metabolic Syndrome and Insulin Resistance Found in Pre-Pubertal Children With Psoriasis
01/29/2021
A high prevalence of metabolic syndrome (MetS) and insulin resistance exists in pre-pubertal children with psoriasis, according to a recent publication in the European Journal of Pediatrics.
A high prevalence of metabolic syndrome (MetS) and insulin resistance exists in pre-pubertal children with psoriasis, according to a recent publication in the European Journal of Pediatrics.
A high prevalence of metabolic...
01/29/2021
The Dermatologist
News
Itch NRS Suitable for Pediatric Psoriasis Population
01/04/2021
Use of the Itch Numeric Rating Scale (NRS) in adults with psoriasis is common, but standard use in a similar pediatric population has not been established. A qualitative study supports the content validity of the Itch NRS for pediatric...
Use of the Itch Numeric Rating Scale (NRS) in adults with psoriasis is common, but standard use in a similar pediatric population has not been established. A qualitative study supports the content validity of the Itch NRS for pediatric...
Use of the Itch Numeric Rating...
01/04/2021
The Dermatologist
Q&As
Amplifying the Voice of Women in Pediatric Dermatology
12/14/2020
Lauren Mateja
Women have found an increasing presence throughout dermatology both at a general and subspecialty level, but gaps in representation remain.  Over the past decade, women have found a growing role in the...
Women have found an increasing presence throughout dermatology both at a general and subspecialty level, but gaps in representation remain.  Over the past decade, women have found a growing role in the...
...
12/14/2020
The Dermatologist

Expert Insights

CH
Videos
How to Teach Families About Safe Hair Care for Skin of Color
01/17/2022
Candrice Heath, MD, FAAP, FAAD
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses...
01/17/2022
The Dermatologist
CH
Videos
Integrating Skin of Color Hair Care for Young Patients
01/09/2022
Candrice Heath, MD, FAAP, FAAD
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath,...
01/09/2022
The Dermatologist
Q&As
Amplifying the Voice of Women in Pediatric Dermatology
12/14/2020
Lauren Mateja
Women have found an increasing presence throughout dermatology both at a general and subspecialty level, but gaps in representation remain.  Over the past decade, women have found a growing role in the...
Women have found an increasing presence throughout dermatology both at a general and subspecialty level, but gaps in representation remain.  Over the past decade, women have found a growing role in the...
...
12/14/2020
The Dermatologist
eee
Podcasts
Dr Heath Shares Clinical Pearls for Treating Pediatric Patients
10/02/2020
Candrice Heath, MD, shared her insights on treating pediatric patients, and why it is important for all dermatologists, including those who only see adults, to learn about treating younger patients.
Candrice Heath, MD, shared her insights on treating pediatric patients, and why it is important for all dermatologists, including those who only see adults, to learn about treating younger patients.
Candrice Heath, MD, shared her...
10/02/2020
The Dermatologist
Cover Story
More to Skin Than Meets the Eye: Bullying and Childhood Skin Conditions
09/11/2020
Sasha D. Jaquez, PhD; Maria A. Leszczynska, MD
Bullying is common in childhood, and children with visible skin conditions can be highly vulnerable. Dermatologists can play a critical role into helping their pediatric patients through early screening and management.
Bullying is common in childhood, and children with visible skin conditions can be highly vulnerable. Dermatologists can play a critical role into helping their pediatric patients through early screening and management.
Bullying is common in childhood,...
09/11/2020
The Dermatologist
Feature Story
Treating Molluscum Contagiosum: Current Choices vs the Future Pipeline
02/13/2020
Without approved treatment options for molluscum contagiosum, doctors have differing opinions on how and even whether to treat. Recent interviews with dermatologists and pediatricians offer insight into the treatments that these two...
Without approved treatment options for molluscum contagiosum, doctors have differing opinions on how and even whether to treat. Recent interviews with dermatologists and pediatricians offer insight into the treatments that these two...
Without approved treatment...
02/13/2020
The Dermatologist
Part 5 panel
Videos
Safety Monitoring in High-Risk CSCC
06/24/2026
Christopher Barker, MD; Krupal Patel, MD, MSc, FRCSC, FACS; John Strasswimmer, MD, PhD, FAAD, FACMS; Deborah J.L. Wong, MD, PhD
The roundtable discussion concludes with a review of the safety profile of adjuvant cemiplimab and best practices for monitoring and managing adverse events in patients with high-risk CSCC, with an emphasis on multidisciplinary follow-up,...
The roundtable discussion concludes with a review of the safety profile of adjuvant cemiplimab and best practices for monitoring and managing adverse events in patients with high-risk CSCC, with an emphasis on multidisciplinary follow-up,...
The roundtable discussion...
06/24/2026
The Dermatologist
Video 2 Drs Strasswimmer and Wong
Videos
Applying High-Risk Criteria in CSCC Practice
06/24/2026
Christopher Barker, MD; Krupal Patel, MD, MSc, FRCSC, FACS; John Strasswimmer, MD, PhD, FAAD, FACMS; Deborah J.L. Wong, MD, PhD
The case-based discussion continues with an exploration of how high-risk features inform treatment decisions in clinical practice. The multidisciplinary panel discusses real-world application of C-POST eligibility criteria and the importance...
The case-based discussion continues with an exploration of how high-risk features inform treatment decisions in clinical practice. The multidisciplinary panel discusses real-world application of C-POST eligibility criteria and the importance...
The case-based discussion...
06/24/2026
The Dermatologist
Part 3 panel
Videos
Multidisciplinary Coordination in High-Risk CSCC
06/24/2026
Christopher Barker, MD; Krupal Patel, MD, MSc, FRCSC, FACS; John Strasswimmer, MD, PhD, FAAD, FACMS; Deborah J.L. Wong, MD, PhD
In this video, the panel highlights the importance of early multidisciplinary collaboration in the management of high-risk CSCC. The experts discuss evolving referral patterns, the role of the tumor board, and the importance of coordinated...
In this video, the panel highlights the importance of early multidisciplinary collaboration in the management of high-risk CSCC. The experts discuss evolving referral patterns, the role of the tumor board, and the importance of coordinated...
In this video, the panel...
06/24/2026
The Dermatologist
Part 2 Patel and Barker
Videos
Integrating Adjuvant Therapy in High-Risk CSCC
06/24/2026
Christopher Barker, MD; Krupal Patel, MD, MSc, FRCSC, FACS; John Strasswimmer, MD, PhD, FAAD, FACMS; Deborah J.L. Wong, MD, PhD
The discussion turns to the role of adjuvant therapy for patients with high-risk CSCC, highlighting key findings from the C-POST trial. Through case-based discussion, the panel explores patient selection, treatment sequencing, and practical...
The discussion turns to the role of adjuvant therapy for patients with high-risk CSCC, highlighting key findings from the C-POST trial. Through case-based discussion, the panel explores patient selection, treatment sequencing, and practical...
The discussion turns to the role...
06/24/2026
The Dermatologist
Drs Patel, Barker, Strasswimmer, and Wong
Videos
Recognizing High-Risk CSCC
06/24/2026
Christopher Barker, MD; Krupal Patel, MD, MSc, FRCSC, FACS; John Strasswimmer, MD, PhD, FAAD, FACMS; Deborah J.L. Wong, MD, PhD
In this video, the multidisciplinary panel reviews the clinical, pathologic, and patient-related features that define high-risk CSCC, including tumor characteristics, nodal involvement, perineural invasion, and immunocompromised status. The...
In this video, the multidisciplinary panel reviews the clinical, pathologic, and patient-related features that define high-risk CSCC, including tumor characteristics, nodal involvement, perineural invasion, and immunocompromised status. The...
In this video, the...
06/24/2026
The Dermatologist
Elliott Campbell
Videos
Innovations in Systemic Therapy for Advanced Nonmelanoma Skin Cancers
06/10/2026
Elliott Campbell, MD, FAAD; Riya Gandhi, MA
Explore the evolving treatment landscape for advanced basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (CSCC).
Explore the evolving treatment landscape for advanced basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (CSCC).
Explore the evolving treatment...
06/10/2026
The Dermatologist
Cover Story
To Screen or Not to Screen? Rethinking Biologic Monitoring in the Modern Era
06/08/2026
Scott Andrew Elman, MD, FAAD
Dermatologists who build vaccination review, mechanism-specific monitoring, and shared decisionmaking into their standard biologic workflow will be better positioned to give their patients safer and more efficient care.
Dermatologists who build vaccination review, mechanism-specific monitoring, and shared decisionmaking into their standard biologic workflow will be better positioned to give their patients safer and more efficient care.
Dermatologists who build...
06/08/2026
The Dermatologist
green
Videos
Hormonal Therapy in Acne: DHT, Spironolactone, and Clascoterone
06/04/2026
Lawrence J. Green, MD, FAAD; Riya Gandhi, MA
Dr Lawrence Green discusses how androgens and DHT contribute to acne pathogenesis through sebum production, inflammation, and abnormal keratinization.
Dr Lawrence Green discusses how androgens and DHT contribute to acne pathogenesis through sebum production, inflammation, and abnormal keratinization.
Dr Lawrence Green discusses how...
06/04/2026
The Dermatologist
Minokadeh
Videos
Injectables for the Male Face: Neuromodulator Dosing and Filler Techniques
06/04/2026
Ardalan Minokadeh, MD, PhD; Riya Gandhi, MA
Dr Ardalan Minokadeh discusses how injectable treatments should be tailored to male facial anatomy, including differences in muscle mass, brow shape, jaw structure, and midface contours.
Dr Ardalan Minokadeh discusses how injectable treatments should be tailored to male facial anatomy, including differences in muscle mass, brow shape, jaw structure, and midface contours.
Dr Ardalan Minokadeh discusses...
06/04/2026
The Dermatologist
Ablon
Videos
Dermatology Retail and Skincare Recommendations: Evidence-Based Strategies for Practices
06/04/2026
Glynis Ablon; Riya Gandhi, MA
Dr Glynis Ablon discusses how dermatology practices can build a clinically driven skincare retail strategy grounded in evidence-based care rather than marketing trends.
Dr Glynis Ablon discusses how dermatology practices can build a clinically driven skincare retail strategy grounded in evidence-based care rather than marketing trends.
Dr Glynis Ablon discusses how...
06/04/2026
The Dermatologist

News and Quizzes

FDA Alerts
FDA Approves Vyjuvek for Treatment of Wounds in Patients with Dystrophic Epidermolysis Bullosa
08/10/2023
Jessica Garlewicz
The US Food and Drug Administration recently announced approval of VYJUVEK (beremagene geperpavec [B-VEC]) for the treatment of wounds in patients ages 6 months and older with dystrophic epidermolysis bullosa.
The US Food and Drug Administration recently announced approval of VYJUVEK (beremagene geperpavec [B-VEC]) for the treatment of wounds in patients ages 6 months and older with dystrophic epidermolysis bullosa.
The US Food and Drug...
08/10/2023
The Dermatologist
News
Patients With Pediatric Granuloma Annulare Often Present With Asthma and Atopy
01/31/2023
Lisa Kuhns, PhD, MD
Researchers aimed to perform a clinical and histopathologic evaluation of 41 pediatric GA cases in a retrospective study.
Researchers aimed to perform a clinical and histopathologic evaluation of 41 pediatric GA cases in a retrospective study.
Researchers aimed to perform a...
01/31/2023
The Dermatologist
News
Tobacco Exposure Linked to Childhood Psoriasis
12/23/2021
Lauren Mateja
A study in Pediatric Dermatology found that environmental tobacco smoke exposure at home was associated with childhood psoriasis in a Turkish population study.
A study in Pediatric Dermatology found that environmental tobacco smoke exposure at home was associated with childhood psoriasis in a Turkish population study.
A study in Pediatric Dermatology...
12/23/2021
The Dermatologist
News
Paraben Exposure Increases Atopic Dermatitis Prevalence in Young Children
12/18/2021
Lisa Kuhns, PhD, MD
High exposure to parabens in children aged 0 to 3 years increased the prevalence of atopic dermatitis (AD), according to a recent study from Japan.
High exposure to parabens in children aged 0 to 3 years increased the prevalence of atopic dermatitis (AD), according to a recent study from Japan.
High exposure to parabens in...
12/18/2021
The Dermatologist
News
Atopic Dermatitis Associated With Shorter Stature and Higher BMI in Children
12/13/2021
Lisa Kuhns, PhD, MD
Atopic dermatitis in children is associated with shorter stature, higher BMI, and lower weight in early childhood, but these associations resolve with age.
Atopic dermatitis in children is associated with shorter stature, higher BMI, and lower weight in early childhood, but these associations resolve with age.
Atopic dermatitis in children is...
12/13/2021
The Dermatologist
News
Pediatric Urticaria Resolution Associated With Elevated CD63 Levels and Thyroid Comorbidity
04/13/2021
Elevated CD63 levels and thyroid disease are associated with chronic inducible urticaria (CIndU) resolution in pediatric patients.
Elevated CD63 levels and thyroid disease are associated with chronic inducible urticaria (CIndU) resolution in pediatric patients.
Elevated CD63 levels and thyroid...
04/13/2021
The Dermatologist
Quiz
Type 2 Endotypes and Therapeutic Strategy in Prurigo Nodularis
06/25/2026
Riya Gandhi, MA
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type...
06/25/2026
The Dermatologist
itch
Quiz
Fibrosis and Persistent Itch in Prurigo Nodularis
06/15/2026
Riya Gandhi, MA
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding...
06/15/2026
The Dermatologist
FDA Alert
FDA Alerts
FDA Approves Every-8-Week Maintenance Dosing Option for Lebrikizumab in Atopic Dermatitis
06/10/2026
Jessica Garlewicz
The FDA approved an every-8-week maintenance dosing regimen for Ebglyss (lebrikizumab-lbkz), providing a new administration option for adults and adolescents aged 12 years and older weighing at least 40 kg with moderate-to-severe atopic...
The FDA approved an every-8-week maintenance dosing regimen for Ebglyss (lebrikizumab-lbkz), providing a new administration option for adults and adolescents aged 12 years and older weighing at least 40 kg with moderate-to-severe atopic...
The FDA approved an every-8-week...
06/10/2026
The Dermatologist
brain
Quiz
Neuroimmune Mechanisms and Cytokine Signaling in Prurigo Nodularis
06/05/2026
Riya Gandhi, MA
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in...
06/05/2026
The Dermatologist
Quiz
Predicting Disease Severity and Persistence in Pediatric Atopic Dermatitis
04/15/2026
Riya Gandhi, MA
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in...
04/15/2026
The Dermatologist
Quiz
Type 2 Inflammation and Early Systemic Therapy in Pediatric Atopic Dermatitis
04/05/2026
Riya Gandhi, MA
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical...
04/05/2026
The Dermatologist
psoriasis0
News
Altered Lysine Crotonylation Identified in Psoriatic Skin
03/19/2026
Jessica Garlewicz
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a...
03/19/2026
The Dermatologist
FDA Alerts
FDA Approves Icotyde (icotrokinra) for the Treatment of Moderate-To-Severe Plaque Psoriasis in Adults and Pediatric Patients
03/18/2026
Jessica Garlewicz
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug...
03/18/2026
The Dermatologist
FDA Alerts
FDA Approves Cosentyx for the Treatment of Pediatric Patients Aged 12 Years and Older With Moderate-To-Severe Hidradenitis Suppurativa
03/17/2026
Jessica Garlewicz
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug...
03/17/2026
The Dermatologist
Quiz
Disease Heterogeneity in PN
03/15/2026
Riya Gandhi, MA
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of...
03/15/2026
The Dermatologist
June 2026 issue

Current Issue

June 2026
Volume 34
Issue 4
Current Issue
Issue Archive
The Dermatologist Newsletter

Recent News

FDA Alerts
FDA Approves Vyjuvek for Treatment of Wounds in Patients with Dystrophic Epidermolysis Bullosa
08/10/2023
Jessica Garlewicz
The US Food and Drug Administration recently announced approval of VYJUVEK (beremagene geperpavec [B-VEC]) for the treatment of wounds in patients ages 6 months and older with dystrophic epidermolysis bullosa.
The US Food and Drug Administration recently announced approval of VYJUVEK (beremagene geperpavec [B-VEC]) for the treatment of wounds in patients ages 6 months and older with dystrophic epidermolysis bullosa.
The US Food and Drug...
08/10/2023
The Dermatologist
News
Patients With Pediatric Granuloma Annulare Often Present With Asthma and Atopy
01/31/2023
Lisa Kuhns, PhD, MD
Researchers aimed to perform a clinical and histopathologic evaluation of 41 pediatric GA cases in a retrospective study.
Researchers aimed to perform a clinical and histopathologic evaluation of 41 pediatric GA cases in a retrospective study.
Researchers aimed to perform a...
01/31/2023
The Dermatologist
News
Tobacco Exposure Linked to Childhood Psoriasis
12/23/2021
Lauren Mateja
A study in Pediatric Dermatology found that environmental tobacco smoke exposure at home was associated with childhood psoriasis in a Turkish population study.
A study in Pediatric Dermatology found that environmental tobacco smoke exposure at home was associated with childhood psoriasis in a Turkish population study.
A study in Pediatric Dermatology...
12/23/2021
The Dermatologist
News
Paraben Exposure Increases Atopic Dermatitis Prevalence in Young Children
12/18/2021
Lisa Kuhns, PhD, MD
High exposure to parabens in children aged 0 to 3 years increased the prevalence of atopic dermatitis (AD), according to a recent study from Japan.
High exposure to parabens in children aged 0 to 3 years increased the prevalence of atopic dermatitis (AD), according to a recent study from Japan.
High exposure to parabens in...
12/18/2021
The Dermatologist
News
Atopic Dermatitis Associated With Shorter Stature and Higher BMI in Children
12/13/2021
Lisa Kuhns, PhD, MD
Atopic dermatitis in children is associated with shorter stature, higher BMI, and lower weight in early childhood, but these associations resolve with age.
Atopic dermatitis in children is associated with shorter stature, higher BMI, and lower weight in early childhood, but these associations resolve with age.
Atopic dermatitis in children is...
12/13/2021
The Dermatologist
News
Pediatric Urticaria Resolution Associated With Elevated CD63 Levels and Thyroid Comorbidity
04/13/2021
Elevated CD63 levels and thyroid disease are associated with chronic inducible urticaria (CIndU) resolution in pediatric patients.
Elevated CD63 levels and thyroid disease are associated with chronic inducible urticaria (CIndU) resolution in pediatric patients.
Elevated CD63 levels and thyroid...
04/13/2021
The Dermatologist
FDA Alert
FDA Alerts
FDA Approves Every-8-Week Maintenance Dosing Option for Lebrikizumab in Atopic Dermatitis
06/10/2026
Jessica Garlewicz
The FDA approved an every-8-week maintenance dosing regimen for Ebglyss (lebrikizumab-lbkz), providing a new administration option for adults and adolescents aged 12 years and older weighing at least 40 kg with moderate-to-severe atopic...
The FDA approved an every-8-week maintenance dosing regimen for Ebglyss (lebrikizumab-lbkz), providing a new administration option for adults and adolescents aged 12 years and older weighing at least 40 kg with moderate-to-severe atopic...
The FDA approved an every-8-week...
06/10/2026
The Dermatologist
psoriasis0
News
Altered Lysine Crotonylation Identified in Psoriatic Skin
03/19/2026
Jessica Garlewicz
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a...
03/19/2026
The Dermatologist
FDA Alerts
FDA Approves Icotyde (icotrokinra) for the Treatment of Moderate-To-Severe Plaque Psoriasis in Adults and Pediatric Patients
03/18/2026
Jessica Garlewicz
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug...
03/18/2026
The Dermatologist
FDA Alerts
FDA Approves Cosentyx for the Treatment of Pediatric Patients Aged 12 Years and Older With Moderate-To-Severe Hidradenitis Suppurativa
03/17/2026
Jessica Garlewicz
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug...
03/17/2026
The Dermatologist
AD
News
Mixed Associations Between Socioeconomic Status and Pediatric Atopic Dermatitis Highlight Research Gaps
03/11/2026
Jessica Garlewicz
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to...
03/11/2026
The Dermatologist
FDA Alerts
FDA Approves Sotyktu for the Treatment of Adults with Active Psoriatic Arthritis
03/10/2026
Jessica Garlewicz
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food...
03/10/2026
The Dermatologist
random
News
Biologic Therapy Improves Psychological Well-Being and Quality of Life in Psoriasis
03/03/2026
Jessica Garlewicz
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for...
03/03/2026
The Dermatologist
psoriasis
News
Low Prevalence but Meaningful Impact of Psychological Symptoms Seen in Well-Controlled Psoriasis
02/03/2026
Jessica Garlewicz
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms...
02/03/2026
The Dermatologist
psoriasis
News
Mathematical Modeling Study Highlights Cytokine Balance and Stem Cell Feedback in Psoriasis Control
01/22/2026
Jessica Garlewicz
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study...
01/22/2026
The Dermatologist
Cutaneous Squamous Cell Carcinoma
News
Managing Cutaneous Squamous Cell Carcinoma
01/06/2026
Jessica Garlewicz
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review...
01/06/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use